By Paul Ziobro
Stryker cut its adjusted profit outlook for the year due to an expected $200 million hit from tariffs.
The Portage, Mich.-based medical technology company on Thursday reported a first-quarter profit of $654 million, or $1.69 a share, compared with $788 million, or $2.05 a share, in the same quarter a year earlier.
Adjusted earnings were $2.84 a share. Analysts polled by FactSet expected $2.71 a share.
Sales rose 11.9% to $5.87 billion, ahead of the $5.69 billion expected by analysts. MedSurg and Neurotechnology sales rose 13.4% while Orthopaedics sales rose 9.7%.
Profit in the quarter fell due to higher expenses.
Stryker lowered its outlook for adjusted earnings per share to between $13.20 and $13.45 from its prior range of between $13.45 and $13.70, citing the expected tariff impact, which it said reflects its best estimate based on current information.
The company also raised its sales outlook for the year, now expecting organic sales growth between 8.5% and 9.5%, up from its prior range between 8% and 9%.
Write to Paul Ziobro at paul.ziobro@wsj.com
(END) Dow Jones Newswires
May 01, 2025 16:41 ET (20:41 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。